mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Advanced Esophageal Adenocarcinoma · Advanced Gastric Adenocarcinoma · Advanced Gastroesophageal Junction Adenocarcinoma · Clinical Stage III Esophageal Adenocarcinoma AJCC v8 · Clinical Stage III Gastric Cancer AJCC v8 · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 · Clinical Stage IV Gastric Cancer AJCC v8 · Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Metastatic Esophageal Adenocarcinoma · Metastatic Gastric Adenocarcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Unresectable Esophageal Adenocarcinoma · Unresectable Gastric Adenocarcinoma · Unresectable Gastroesophageal Junction Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

  • Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · AKPAMC.OncologyResearchSupport@providence.org · 907-212-6871
    Contact: Principal Investigator (Alison K. Conlin)
  • Anchorage Radiation Therapy Center, Anchorage, Alaska, United States

  • Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · AKPAMC.OncologyResearchSupport@providence.org · 907-212-6871
    Contact: Principal Investigator (Alison K. Conlin)
  • Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · AKPAMC.OncologyResearchSupport@providence.org · 907-212-6871
    Contact: Principal Investigator (Alison K. Conlin)
  • Alaska Women's Cancer Care, Anchorage, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · AKPAMC.OncologyResearchSupport@providence.org · 907-212-6871
    Contact: Principal Investigator (Alison K. Conlin)
  • Anchorage Oncology Centre, Anchorage, Alaska, United States

  • Katmai Oncology Group, Anchorage, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · AKPAMC.OncologyResearchSupport@providence.org · 907-212-6871
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Alaska Medical Center, Anchorage, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · AKPAMC.OncologyResearchSupport@providence.org · 907-212-6871
    Contact: Principal Investigator (Alison K. Conlin)
  • Fairbanks Memorial Hospital, Fairbanks, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · Veronica.Stevenson@foundationhealth.org · 907-458-3043
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kingman Regional Medical Center, Kingman, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Cancer Center at Saint Joseph's, Phoenix, Arizona, United States

  • Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 800-378-9373
    Contact: Principal Investigator (Jay W. Carlson)
  • CARTI Cancer Center, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · Research@CARTI.com · 501-906-4199
    Contact: Principal Investigator (Jay W. Carlson)
  • Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States

  • PCR Oncology, Arroyo Grande, California, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Sutter Auburn Faith Hospital, Auburn, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States

    Contact: Study coordinator (Site Public Contact) · Najee.Boucher@providence.org · 818-847-4793
    Contact: Principal Investigator (Alison K. Conlin)
  • Mills-Peninsula Medical Center, Burlingame, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Mercy Cancer Center - Carmichael, Carmichael, California, United States

  • Mercy San Juan Medical Center, Carmichael, California, United States

  • Eden Hospital Medical Center, Castro Valley, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • UC Irvine Health Cancer Center-Newport, Costa Mesa, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-827-8839
    Contact: Principal Investigator (Farshid Dayyani)
  • Sutter Davis Hospital, Davis, California, United States

    Contact: Study coordinator (Site Public Contact) · NCIclinicaltrials@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente Dublin, Dublin, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Mercy Cancer Center - Elk Grove, Elk Grove, California, United States

  • Kaiser Permanente-Fremont, Fremont, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Palo Alto Medical Foundation-Fremont, Fremont, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Fresno Cancer Center, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente Fresno Orchard Plaza, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · 833-574-2273
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Fresno, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Farshid Dayyani)
  • Keck Medicine of USC Koreatown, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 213-388-0908
    Contact: Principal Investigator (Syma Iqbal)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Syma Iqbal)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Syma Iqbal)
  • Contra Costa Regional Medical Center, Martinez, California, United States

  • Mercy Cancer Center, Merced, California, United States

  • Memorial Medical Center, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente- Modesto MOB II, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Modesto, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Providence Queen of The Valley, Napa, California, United States

    Contact: Study coordinator (Site Public Contact) · 707-521-3830
    Contact: Principal Investigator (Alison K. Conlin)
  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Syma Iqbal)
  • Sutter Cancer Research Consortium, Novato, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente Oakland-Broadway, Oakland, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Oakland, Oakland, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Farshid Dayyani)
  • Palo Alto Medical Foundation Health Care, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Eisenhower Medical Center, Rancho Mirage, California, United States

    Contact: Study coordinator (Site Public Contact) · 760-834-3798
    Contact: Principal Investigator (Henry T. Tsai)
  • Kaiser Permanente- Marshall Medical Offices, Redwood City, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Richmond, Richmond, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Mercy Cancer Center - Rocklin, Rocklin, California, United States

  • Rohnert Park Cancer Center, Rohnert Park, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Roseville, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Sutter Roseville Medical Center, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente Downtown Commons, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Mercy Cancer Center - Sacramento, Sacramento, California, United States

  • Sutter Medical Center Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente-South Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • South Sacramento Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • California Pacific Medical Center-Pacific Campus, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente-San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente San Leandro, San Leandro, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States

  • Mills Health Center, San Mateo, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser San Rafael-Gallinas, San Rafael, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Ridley-Tree Cancer Center, Santa Barbara, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Santa Cruz Radiation Oncology Medical Group, Santa Cruz, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States

  • Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Providence Medical Foundation - Santa Rosa, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · 707-521-3830
    Contact: Principal Investigator (Alison K. Conlin)
  • Sutter Pacific Medical Foundation, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org · 415-209-2683
    Contact: Principal Investigator (Uma Suryadevara)
  • Providence Santa Rosa Memorial Hospital, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · 707-521-3830
    Contact: Principal Investigator (Alison K. Conlin)
  • Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-South San Francisco, South San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Stockton, Stockton, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kaiser Permanente-Vallejo, Vallejo, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • Sutter Solano Medical Center/Cancer Center, Vallejo, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (Uma Suryadevara)
  • Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Tatjana Kolevska)
  • BASS Medical Group - Lennon, Walnut Creek, California, United States

  • Woodland Memorial Hospital, Woodland, California, United States

  • Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States

  • Boulder Community Foothills Hospital, Boulder, Colorado, United States

  • Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States

  • Intermountain Health Platte Valley Hospital, Brighton, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · peaksresearch@imail.org
    Contact: Principal Investigator (Karng S. Log)
  • Rocky Mountain Cancer Centers - Centennial, Centennial, Colorado, United States

  • Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States

  • Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States

  • UCHealth Memorial Hospital Central, Colorado Springs, Colorado, United States

  • Memorial Hospital North, Colorado Springs, Colorado, United States

  • Saint Francis Cancer Center, Colorado Springs, Colorado, United States

  • Cancer Center of Colorado at Sloan's Lake, Denver, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 303-777-2663
    Contact: Principal Investigator (Karng S. Log)
  • National Jewish Health-Main Campus, Denver, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · glicht@co-cancerresearch.org · 877-225-5654
    Contact: Principal Investigator (Karng S. Log)
  • The Women's Imaging Center, Denver, Colorado, United States

  • AdventHealth Porter, Denver, Colorado, United States

  • Colorado Blood Cancer Institute, Denver, Colorado, United States

  • Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States

  • Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States

  • Saint Joseph Hospital - Cancer Centers of Colorado, Denver, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 303-318-3413
    Contact: Principal Investigator (Karng S. Log)
  • Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States

  • Rose Medical Center, Denver, Colorado, United States

  • CommonSpirit Cancer Center Mercy, Durango, Colorado, United States

  • Mercy Medical Center, Durango, Colorado, United States

  • Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, United States

  • Rocky Mountain Cancer Centers - Swedish, Englewood, Colorado, United States

  • Swedish Medical Center, Englewood, Colorado, United States

  • The Melanoma and Skin Cancer Institute, Englewood, Colorado, United States

  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Lynn M. Mathew)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Lynn M. Mathew)
  • Lutheran Hospital - Cancer Centers of Colorado, Golden, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · peaksresearch@imail.org
    Contact: Principal Investigator (Karng S. Log)
  • National Jewish Health-Western Hematology Oncology, Golden, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · glicht@co-cancerresearch.org · 303-777-2663
    Contact: Principal Investigator (Karng S. Log)
  • Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · ccrp@co-cancerresearch.org · 303-777-2663
    Contact: Principal Investigator (Karng S. Log)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Lynn M. Mathew)
  • Good Samaritan Hospital - Cancer Centers of Colorado, Lafayette, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · peaksresearch@imail.org
    Contact: Principal Investigator (Karng S. Log)
  • CommonSpirit Saint Anthony Hospital Cancer Center, Lakewood, Colorado, United States

  • Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, United States

  • Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States

  • AdventHealth Littleton, Littleton, Colorado, United States

  • Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States

  • Longmont United Hospital, Longmont, Colorado, United States

  • Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States

  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Lynn M. Mathew)
  • AdventHealth Parker, Parker, Colorado, United States

  • Saint Mary Corwin Medical Center, Pueblo, Colorado, United States

  • National Jewish Health-Northern Hematology Oncology, Thornton, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · glicht@co-cancerresearch.org · 303-777-2663
    Contact: Principal Investigator (Karng S. Log)
  • Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado, United States

  • Saint Anthony North Hospital, Westminster, Colorado, United States

  • Intermountain Health Lutheran Hospital, Wheat Ridge, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · peaksresearch@imail.org
    Contact: Principal Investigator (Karng S. Log)
  • Hartford HealthCare - Avon, Avon, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Jaykumar T. Thumar)
  • Hartford Hospital, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-545-5363
    Contact: Principal Investigator (Jaykumar T. Thumar)
  • Hartford HealthCare - Manchester, Manchester, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Jaykumar T. Thumar)
  • Midstate Medical Center, Meriden, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 866-662-5678
    Contact: Principal Investigator (Jaykumar T. Thumar)
  • The Hospital of Central Connecticut, New Britain, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-224-5660
    Contact: Principal Investigator (Jaykumar T. Thumar)
  • Beebe Medical Center, Lewes, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe South Coastal Health Campus, Millville, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States

  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Beebe Health Campus, Rehoboth Beach, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · research@beebehealthcare.org · 302-291-6730
    Contact: Principal Investigator (Gregory A. Masters)
  • Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-444-2223
    Contact: Principal Investigator (Reetu Mukherji)
  • MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-877-8839
    Contact: Principal Investigator (Reetu Mukherji)
  • Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · jquiver1@jhmi.edu · 202-243-2373
    Contact: Principal Investigator (Katherine M. Bever)
  • George Washington University Medical Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-741-2210
    Contact: Principal Investigator (Sonal Paul)
  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura, Florida, United States

    Contact: Study coordinator (Site Public Contact) · yenrique@msmc.com · 305-674-2625
    Contact: Principal Investigator (Mike Cusnir)
  • Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs, Florida, United States

    Contact: Study coordinator (Site Public Contact) · RCCR@leehealth.org · 239-343-9660
    Contact: Principal Investigator (Leandro P. Moraes)
  • Holy Cross Hospital, Fort Lauderdale, Florida, United States

    Contact: Study coordinator (Site Public Contact) · eileen.georgi@holy-cross.com
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Regional Cancer Center-Lee Memorial Health System, Fort Myers, Florida, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Leandro P. Moraes)
  • UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States

  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States

    Contact: Study coordinator (Site Public Contact) · OHR@mhs.net · 954-265-1847
    Contact: Principal Investigator (Jesus C. Fabregas)
  • Jupiter Medical Center, Jupiter, Florida, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@jupitermed.com · 561-263-5791
    Contact: Principal Investigator (Jon DuBois)
  • The Watson Clinic, Lakeland, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 863-680-7780
    Contact: Principal Investigator (Shalini Mulaparthi)
  • Mount Sinai Medical Center, Miami Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · Yvonne.Enriquez@msmc.com · 305-674-2625
    Contact: Principal Investigator (Mike Cusnir)
  • Memorial Hospital West, Pembroke Pines, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 954-265-4325
    Contact: Principal Investigator (Jesus C. Fabregas)
  • Tift Regional Medical Center, Tifton, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 800-648-1935
    Contact: Principal Investigator (Apurva N. Shah)
  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · i.webster@hawaiicancercare.com · 808-524-6115
    Contact: Principal Investigator (Jared D. Acoba)
  • Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-532-0315
    Contact: Principal Investigator (Jared D. Acoba)
  • Queen's Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-545-8548
    Contact: Principal Investigator (Jared D. Acoba)
  • Straub Clinic and Hospital, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-522-4333
    Contact: Principal Investigator (Jared D. Acoba)
  • University of Hawaii Cancer Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-586-2979
    Contact: Principal Investigator (Jared D. Acoba)
  • Hawaii Diagnostic Radiology Services LLC, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · mmiyoshi@hawaiidrs.com · 808-792-7897
    Contact: Principal Investigator (Jared D. Acoba)
  • Kuakini Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-547-9816
    Contact: Principal Investigator (Jared D. Acoba)
  • Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-531-8521
    Contact: Principal Investigator (Jared D. Acoba)
  • The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States

  • Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · shelley.a.clark@kp.org · 808-432-5195
    Contact: Principal Investigator (Tatjana Kolevska)
  • Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-983-6090
    Contact: Principal Investigator (Jared D. Acoba)
  • Straub Medical Center - Kahului Clinic, Kahului, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · lori.kam@hawaiipacifichealth.org
    Contact: Principal Investigator (Jared D. Acoba)
  • Castle Medical Center, Kailua, Hawaii, United States

  • Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-535-7960
    Contact: Principal Investigator (Jared D. Acoba)
  • Hawaii Cancer Care - Westridge, ‘Aiea, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · info@hawaiicancercare.com · 808-539-2273
    Contact: Principal Investigator (Jared D. Acoba)
  • Pali Momi Medical Center, ‘Aiea, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-486-6000
    Contact: Principal Investigator (Jared D. Acoba)
  • Queen's Cancer Center - Pearlridge, ‘Aiea, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · 808-487-7447
    Contact: Principal Investigator (Jared D. Acoba)
  • The Cancer Center of Hawaii-Pali Momi, ‘Aiea, Hawaii, United States

  • The Queen's Medical Center - West Oahu, ‘Ewa Beach, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · rohta@queens.org
    Contact: Principal Investigator (Jared D. Acoba)
  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Walter Knox Memorial Hospital, Emmett, Idaho, United States

  • Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Idaho Urologic Institute-Meridian, Meridian, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Alison K. Conlin)
  • OSF Saint Anthony's Health Center, Alton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 618-463-5623
    Contact: Principal Investigator (Jay W. Carlson)
  • Rush-Copley Medical Center, Aurora, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · RCMC_Cancer_Research@rush.edu · 630-978-6212
    Contact: Principal Investigator (Tanmay Sahai)
  • Advocate Outpatient Center - Aurora, Aurora, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aah.org
    Contact: Principal Investigator (Edward S. James)
  • Advocate Good Shepherd Hospital, Barrington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-842-4847
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Canton, Canton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Memorial Hospital of Carbondale, Carbondale, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinical.research@sih.net · 618-457-5200
    Contact: Principal Investigator (Bryan A. Faller)
  • SIH Cancer Institute, Carterville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinical.research@sih.net · 618-985-3333
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Carthage, Carthage, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Centralia Oncology Clinic, Centralia, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Saint Mary's Hospital, Centralia, Illinois, United States

  • Mount Sinai Hospital Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · suhi@sinai.org · 773-257-5960
    Contact: Principal Investigator (Pam G. Khosla)
  • John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-864-5204
    Contact: Principal Investigator (Deimante M. Tamkus)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Yolande Chen)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Manik A. Amin)
  • Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-296-5360
    Contact: Principal Investigator (Edward S. James)
  • AMG Crystal Lake - Oncology, Crystal Lake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocate.com · 630-929-6129
    Contact: Principal Investigator (Edward S. James)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Dixon, Dixon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 815-285-7800
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Barbara.barhamand@advocatehealth.com · 630-275-1270
    Contact: Principal Investigator (Edward S. James)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Sherman Hospital, Elgin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-429-2907
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States

  • Ingalls Memorial Hospital, Harvey, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@ingalls.org · 708-915-4673
    Contact: Principal Investigator (James A. Wallace)
  • Advocate South Suburban Hospital, Hazel Crest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 708-799-9995
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • AMG Libertyville - Oncology, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Edward S. James)
  • Condell Memorial Hospital, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • Trinity Medical Center, Moline, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 309-779-2000
    Contact: Principal Investigator (Tanmay Sahai)
  • SSM Health Good Samaritan, Mount Vernon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · gayla.hall@ssmhealth.com · 618-899-1894
    Contact: Principal Investigator (Jay W. Carlson)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Manik A. Amin)
  • Carle Cancer Institute Normal, Normal, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Christ Medical Center, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-323-8622
    Contact: Principal Investigator (Edward S. James)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Manik A. Amin)
  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-384-3621
    Contact: Principal Investigator (Edward S. James)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Methodist Medical Center of Illinois, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peru, Peru, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Valley Radiation Oncology, Peru, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 815-664-4141
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • OSF Saint Anthony Medical Center, Rockford, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 815-227-2633
    Contact: Principal Investigator (Shylendra B. Sreenivasappa)
  • UW Health Carbone Cancer Center Rockford, Rockford, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · lkline@uwhealth.org · 779-696-9378
    Contact: Principal Investigator (Fahrettin Covut)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Tanmay Sahai)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Rush-Copley Healthcare Center, Yorkville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancer.Research@rushcopley.com · 630-978-6212
    Contact: Principal Investigator (Tanmay Sahai)
  • Northwest Cancer Center - Crown Point, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@powershealth.org · 219-836-6879
    Contact: Principal Investigator (Tanmay Sahai)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Manik A. Amin)
  • Northwest Oncology LLC, Dyer, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-924-8178
    Contact: Principal Investigator (Tanmay Sahai)
  • Northwest Cancer Center - Hobart, Hobart, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-947-1795
    Contact: Principal Investigator (Tanmay Sahai)
  • Saint Mary Medical Center, Hobart, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Tanmay Sahai)
  • Saint Catherine Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Tanmay Sahai)
  • The Community Hospital, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-836-3349
    Contact: Principal Investigator (Tanmay Sahai)
  • Women's Diagnostic Center - Munster, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · mnicholson@comhs.org · 219-934-8869
    Contact: Principal Investigator (Tanmay Sahai)
  • Reid Health, Richmond, Indiana, United States

  • Northwest Cancer Center - Valparaiso, Valparaiso, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Tanmay Sahai)
  • Mary Greeley Medical Center, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · katherine-daprile@uiowa.edu · 563-355-7733
    Contact: Principal Investigator (Saima Sharif)
  • McFarland Clinic - Boone, Boone, Iowa, United States

  • Mercy Hospital, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-365-4673
    Contact: Principal Investigator (Deborah W. Wilbur)
  • Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 319-363-2690
    Contact: Principal Investigator (Deborah W. Wilbur)
  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States

  • Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 712-322-4136
    Contact: Principal Investigator (Timothy Huyck)
  • Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · kathryn.bartz@nmhs.org · 402-354-7939
    Contact: Principal Investigator (Timothy Huyck)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (Saima Sharif)
  • McFarland Clinic - Jefferson, Jefferson, Iowa, United States

  • McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Healthcare Mission Cancer and Blood - Pella, Pella, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · trials@missioncancer.com · 515-282-2921
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Siouxland Regional Cancer Center, Sioux City, Iowa, United States

  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Central Care Cancer Center - Garden City, Garden City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · aroland@kccop.org · 913-948-5588
    Contact: Principal Investigator (Jay W. Carlson)
  • Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · aroland@kccop.org · 913-948-5588
    Contact: Principal Investigator (Jay W. Carlson)
  • HaysMed, Hays, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-623-5774
    Contact: Principal Investigator (Gary C. Doolittle)
  • Lawrence Memorial Hospital, Lawrence, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.Norris@LMH.ORG · 785-505-2800
    Contact: Principal Investigator (Gary C. Doolittle)
  • The University of Kansas Cancer Center - Olathe, Olathe, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · OlatheCCResearch@kumc.edu · 913-588-1569
    Contact: Principal Investigator (Gary C. Doolittle)
  • Freeman Physician Group of Pittsburg, Pittsburg, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · BNMathew@freemanhealth.com
    Contact: Principal Investigator (Gary C. Doolittle)
  • Mercy Hospital Pittsburg, Pittsburg, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 888-446-3729
    Contact: Principal Investigator (Jay W. Carlson)
  • Salina Regional Health Center, Salina, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · mleepers@srhc.com · 785-452-7038
    Contact: Principal Investigator (Gary C. Doolittle)
  • University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-295-8000
    Contact: Principal Investigator (Gary C. Doolittle)
  • CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown, Kentucky, United States

  • Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States

  • CommonSpirit Saint Joseph Hospital - Lexington, Lexington, Kentucky, United States

  • Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States

  • CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington, Kentucky, United States

  • University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States

  • CommonSpirit Saint Joseph Hospital London, London, Kentucky, United States

  • The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 502-562-3429
    Contact: Principal Investigator (Anika Bhargava)
  • UofL Health Medical Center Northeast, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · ctoinfo@louisville.edu · 502-852-2755
    Contact: Principal Investigator (Anika Bhargava)
  • CommonSpirit Saint Joseph Hospital Mount Sterling, Mount Sterling, Kentucky, United States

  • Mercy Health - Paducah Cancer Center, Paducah, Kentucky, United States

  • University Medical Center New Orleans, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Thomas M. Reske)
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · jhcccro@jhmi.edu · 410-955-8804
    Contact: Principal Investigator (Katherine M. Bever)
  • Christiana Care - Union Hospital, Elkton, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · frank.crum@christianacare.org · 410-443-1360
    Contact: Principal Investigator (Gregory A. Masters)
  • Boston Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 617-638-8265
    Contact: Principal Investigator (Gretchen A. Gignac)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-442-3324
    Contact: Principal Investigator (Haeseong Park)
  • Dana-Farber Cancer Institute at Boston Medical Center - Brighton, Brighton, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 617-789-2903
    Contact: Principal Investigator (Alys Malcolm)
  • Dana-Farber Cancer Institute at Foxborough, Foxborough, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-338-7425
    Contact: Principal Investigator (Naeem Tahir)
  • Dana Farber-Merrimack Valley, Methuen, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-338-7425
    Contact: Principal Investigator (Pedro M. Sanz-Altamira)
  • Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-332-4294
    Contact: Principal Investigator (Humberto A. Rossi)
  • Dana-Farber/Brigham and Women's Cancer Center at South Shore, South Weymouth, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 781-624-5000
    Contact: Principal Investigator (Thomas P. O'Connor)
  • Hickman Cancer Center, Adrian, Michigan, United States

  • MyMichigan Medical Center Gratiot, Alma, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CVResearch@mymichigan.org · 989-631-2469
    Contact: Principal Investigator (Christopher M. Reynolds)
  • MyMichigan Medical Center Alpena, Alpena, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CVResearch@mymichigan.org · 989-631-2469
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • McLaren Cancer Institute-Bay City, Bay City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Medical Center - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Medical Center - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Caro Cancer Center, Caro, Michigan, United States

  • Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • McLaren Cancer Institute-Clarkston, Clarkston, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • Newland Medical Associates-Clarkston, Clarkston, Michigan, United States

  • Corewell Health Dearborn Hospital, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 800-527-6266
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • Henry Ford Health Saint John Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · Kkeenan1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford River District Hospital, East China Township, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • OSF Saint Francis Hospital and Medical Group, Escanaba, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • Corewell Health Farmington Hills Hospital, Farmington Hills, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Cancer Hematology Centers - Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Genesee Hematology Oncology PC, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Hurley Medical Center, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Christopher M. Reynolds)
  • McLaren Cancer Institute-Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • MyMichigan Medical Center Gladwin, Gladwin, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CVResearch@mymichigan.org · 989-631-2469
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Saint John Hospital - Academic, Grosse Pointe Woods, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Saint John Hospital - Breast, Grosse Pointe Woods, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · karen.forman@ascension.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Saint John Hospital - Van Elslander, Grosse Pointe Woods, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Karmanos Cancer Institute at McLaren Greater Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (Christopher M. Reynolds)
  • McLaren Cancer Institute-Lapeer Region, Lapeer, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Saint John Hospital - Macomb Medical, Macomb, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Warren Hospital - Breast Macomb, Macomb, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States

  • MyMichigan Medical Center Midland, Midland, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CVResearch@mymichigan.org · 989-631-2469
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, United States

  • McLaren Cancer Institute-Macomb, Mount Clemens, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • MyMichigan Medical Center Mount Pleasant, Mount Pleasant, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CVResearch@mymichigan.org · 989-631-2469
    Contact: Principal Investigator (Christopher M. Reynolds)
  • McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • Hope Cancer Center, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Michigan Healthcare Professionals Pontiac, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · Emily.Crofts@trinity-health.org · 248-858-6215
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Newland Medical Associates-Pontiac, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • McLaren-Port Huron, Port Huron, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Mohammed N. Al Hallak)
  • Oakland Colon Rectal Associates, Royal Oak, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Cancer Care Associates PC, Royal Oak, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Comprehensive Medical Center PLLC, Royal Oak, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Hematology Oncology Consultants PC-Royal Oak, Royal Oak, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Oakland Medical Group, Royal Oak, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • MyMichigan Medical Center Saginaw, Saginaw, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States

  • Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States

  • Premier Hematology Oncology Care, Sterling Heights, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • MyMichigan Medical Center Tawas, Tawas City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Michigan Institute of Urology-Town Center, Troy, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Corewell Health Beaumont Troy Hospital, Troy, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Hematology Oncology Consultants PC-Troy, Troy, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 248-551-7695
    Contact: Principal Investigator (George S. Howard)
  • Advanced Breast Care Center PLLC, Warren, Michigan, United States

  • Henry Ford Health Warren Hospital, Warren, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Madison Heights Hospital - Breast, Warren, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Henry Ford Warren Hospital - GLCMS, Warren, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · kforman1@hfhs.org · 313-343-3166
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Macomb Hematology Oncology PC, Warren, Michigan, United States

  • Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States

  • Huron Gastroenterology PC, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Riverwood Healthcare Center, Aitkin, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health - Baxter Clinic, Baxter, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-828-2880
    Contact: Principal Investigator (Bret E. Friday)
  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Ridges Hospital, Burnsville, Minnesota, United States

  • Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Cambridge Medical Center, Cambridge, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Minnesota Oncology Hematology PA-Chaska, Chaska, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Minnesota Oncology - Coon Rapids, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health - Saint Joseph's Crosslake Clinic, Crosslake, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-692-1010
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health - Deer River Clinic, Deer River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Saint Mary's - Detroit Lakes Clinic, Detroit Lakes, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Cancer Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Miller-Dwan Hospital, Duluth, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Minnesota Oncology - Edina, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health - Ely Clinic, Ely, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-365-7900
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health - Fosston, Fosston, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Unity Hospital, Fridley, Minnesota, United States

  • Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health - International Falls Clinic, International Falls, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-283-9431
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Minnesota Oncology - Maple Grove, Maple Grove, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1572
    Contact: Principal Investigator (Daniel M. Anderson)
  • Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Hennepin County Medical Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Health Partners Inc, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Monticello Cancer Center, Monticello, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health - Moose Lake Clinic, Moose Lake, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-485-4481
    Contact: Principal Investigator (Bret E. Friday)
  • New Ulm Medical Center, New Ulm, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health - Park Rapids, Park Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health - Saint Joseph's Pequot Lakes Clinic, Pequot Lakes, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-568-4416
    Contact: Principal Investigator (Bret E. Friday)
  • Essentia Health - Saint Joseph's Pine River Clinic, Pine River, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-587-4416
    Contact: Principal Investigator (Bret E. Friday)
  • Fairview Northland Medical Center, Princeton, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • North Memorial Medical Health Center, Robbinsdale, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · coborncancercenter@centracare.com · 877-229-4907
    Contact: Principal Investigator (Donald J. Jurgens)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health Sandstone, Sandstone, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Saint Francis Regional Medical Center, Shakopee, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Essentia Health - Saint Joseph's Staples Clinic, Staples, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 218-894-7870
    Contact: Principal Investigator (Bret E. Friday)
  • Lakeview Hospital, Stillwater, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Sanford Thief River Falls Medical Center, Thief River Falls, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health Virginia Clinic, Virginia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Ridgeview Medical Center, Waconia, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Rice Memorial Hospital, Willmar, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Sanford Cancer Center Worthington, Worthington, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Fairview Lakes Medical Center, Wyoming, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 888-446-3729
    Contact: Principal Investigator (Jay W. Carlson)
  • Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · aroland@kccop.org · 913-948-5588
    Contact: Principal Investigator (Jay W. Carlson)
  • Cox Cancer Center Branson, Branson, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • Mercy Cancer Center - Cape Girardeau, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 888-446-3729
    Contact: Principal Investigator (Jay W. Carlson)
  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Parkland Health Center - Farmington, Farmington, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • MU Health Care Goldschmidt Cancer Center, Jefferson City, Missouri, United States

  • Freeman Health System, Joplin, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · LJCrockett@freemanhealth.com · 417-347-4030
    Contact: Principal Investigator (Jay W. Carlson)
  • Mercy Hospital Joplin, Joplin, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · esmeralda.carrillo@mercy.net · 417-556-3074
    Contact: Principal Investigator (Jay W. Carlson)
  • University Health Truman Medical Center, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 816-404-4375
    Contact: Principal Investigator (Gary C. Doolittle)
  • Lake Regional Hospital, Osage Beach, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@lakeregional.com · 573-302-2768
    Contact: Principal Investigator (Jay W. Carlson)
  • Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 573-458-6379
    Contact: Principal Investigator (Jay W. Carlson)
  • Phelps Health Delbert Day Cancer Institute, Rolla, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · research@phelpshealth.org · 573-458-7504
    Contact: Principal Investigator (Jay W. Carlson)
  • Heartland Regional Medical Center, Saint Joseph, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Trisha.England2@mymlc.com · 816-271-7937
    Contact: Principal Investigator (Jay W. Carlson)
  • Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Springfield, Springfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • CoxHealth South Hospital, Springfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • Mercy Infusion Center - Chippewa, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 888-446-3729
    Contact: Principal Investigator (Jay W. Carlson)
  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Washington, Washington, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 636-390-1600
    Contact: Principal Investigator (Jay W. Carlson)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Vincent Healthcare, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Karng S. Log)
  • Saint Vincent Frontier Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · 800-648-6274
    Contact: Principal Investigator (Karng S. Log)
  • Intermountain Health West End Clinic, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · 406-238-6685
    Contact: Principal Investigator (Karng S. Log)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States

    Contact: Study coordinator (Site Public Contact) · 406-723-2621
    Contact: Principal Investigator (Karng S. Log)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Great Falls Clinic, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Hi-Line Sletten Cancer Center, Havre, Montana, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Helena Specialty Center, Helena, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · amy.hanneman@providence.org · 406-327-3118
    Contact: Principal Investigator (Alison K. Conlin)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Mridula Krishnan)
  • CHI Health Saint Francis, Grand Island, Nebraska, United States

  • CHI Health Good Samaritan, Kearney, Nebraska, United States

  • Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States

  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-334-4773
    Contact: Principal Investigator (Timothy Huyck)
  • Nebraska Methodist Hospital, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-354-5144
    Contact: Principal Investigator (Timothy Huyck)
  • Oncology Associates PC, Omaha, Nebraska, United States

  • Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-559-5600
    Contact: Principal Investigator (Mridula Krishnan)
  • Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States

  • Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States

  • Alegent Health Lakeside Hospital, Omaha, Nebraska, United States

  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Mridula Krishnan)
  • Midlands Community Hospital, Papillion, Nebraska, United States

  • Carson Tahoe Regional Medical Center, Carson City, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States

  • Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States

  • Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Urology - Green Valley, Henderson, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Urology - Pebble, Henderson, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Oncology Las Vegas - Henderson, Henderson, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Urology Specialists of Nevada - Green Valley, Henderson, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Urology - Pecos, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • University Medical Center of Southern Nevada, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Hope Cancer Care of Nevada, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Urology Specialists of Nevada - Central, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Prostate Cancer Center, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Urology - Sunset, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Ann M Wierman MD LTD, Las Vegas, Nevada, United States

  • Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@smcrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Oncology Las Vegas - Tenaya, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • OptumCare Cancer Care at MountainView, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org
    Contact: Principal Investigator (John A. Ellerton)
  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Summerlin Hospital Medical Center, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States

  • Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • University Cancer Center, Las Vegas, Nevada, United States

  • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Renown Regional Medical Center, Reno, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Saint Mary's Regional Medical Center, Reno, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Radiation Oncology Associates, Reno, Nevada, United States

  • The Dana-Farber Cancer Institute at Londonderry, Londonderry, New Hampshire, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Jeanna H. Walsh)
  • Jefferson Cherry Hill Hospital, Cherry Hill, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • Sidney Kimmel Cancer Center Washington Township, Sewell, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

  • New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York, United States

    Contact: Study coordinator (Site Public Contact) · Adg9003@nyp.org · 718-780-3677
    Contact: Principal Investigator (Uqba Khan)
  • The New York Hospital Medical Center of Queens, Flushing, New York, United States

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Jini Hyun)
  • Glens Falls Hospital, Glens Falls, New York, United States

    Contact: Study coordinator (Site Public Contact) · 518-926-6700
    Contact: Principal Investigator (Sarah Gillett)
  • Northwell Health Cancer Institute at Huntington, Greenlawn, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Tony Philip)
  • Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Tony Philip)
  • Northern Westchester Hospital, Mount Kisco, New York, United States

    Contact: Study coordinator (Site Public Contact) · AMellor@northwell.edu · 914-666-1366
    Contact: Principal Investigator (Tony Philip)
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States

  • Manhattan Eye Ear and Throat Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-434-4460
    Contact: Principal Investigator (Tony Philip)
  • NYP/Weill Cornell Medical Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-746-1848
    Contact: Principal Investigator (Manish A. Shah)
  • Lenox Hill Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 516-734-8896
    Contact: Principal Investigator (Tony Philip)
  • Queens Cancer Center, Rego Park, New York, United States

    Contact: Study coordinator (Site Public Contact) · 718-312-3446
    Contact: Principal Investigator (Tony Philip)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Maria C. McGreevy)
  • Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States

    Contact: Study coordinator (Site Public Contact) · 914-366-1600
    Contact: Principal Investigator (Tony Philip)
  • Stony Brook University Medical Center, Stony Brook, New York, United States

    Contact: Study coordinator (Site Public Contact) · 800-862-2215
    Contact: Principal Investigator (Julie Anne L. Gemmill)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Fernand Bteich)
  • Montefiore Medical Center-Weiler Hospital, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Fernand Bteich)
  • Wilmot Cancer Institute at Webster, Webster, New York, United States

    Contact: Study coordinator (Site Public Contact) · WCICTOresearch@urmc.rochester.edu
    Contact: Principal Investigator (Maria C. McGreevy)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Ashwin Somasundaram)
  • Wake Forest University at Clemmons, Clemmons, North Carolina, United States

  • Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 919-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • East Carolina University, Greenville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · eubankss@ecu.edu · 252-744-1015
    Contact: Principal Investigator (Mahvish Muzaffar)
  • Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · pardeecancerresearch@unchealth.unc.edu · 828-696-4716
    Contact: Principal Investigator (John K. Hill)
  • University of North Carolina-Hillsborough Campus, Hillsborough, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Ashwin Somasundaram)
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jfields@cancersmoc.com · 910-587-9084
    Contact: Principal Investigator (Samer S. Kasbari)
  • FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jcwilliams@firsthealth.org · 910-715-3500
    Contact: Principal Investigator (Charles S. Kuzma)
  • Wake Forest Baptist Health - Wilkes Medical Center, Wilkesboro, North Carolina, United States

  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Sanford South University Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • Southpointe-Sanford Medical Center Fargo, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Medical Center Fargo, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · 800-437-4010
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • Essentia Health - Jamestown Clinic, Jamestown, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Indu and Raj Soin Medical Center, Beavercreek, Ohio, United States

  • Strecker Cancer Center-Belpre, Belpre, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Saint Elizabeth Boardman Hospital, Boardman, Ohio, United States

  • Cleveland Clinic Mercy Hospital, Canton, Ohio, United States

  • Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, United States

  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Adena Regional Medical Center, Chillicothe, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 877-779-7585
    Contact: Principal Investigator (Aruna C. Gowda)
  • Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States

  • Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio, United States

  • Bethesda North Hospital, Cincinnati, Ohio, United States

  • TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States

  • TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Ning Jin)
  • Mount Carmel East Hospital, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States

  • Riverside Methodist Hospital, Columbus, Ohio, United States

  • Grant Medical Center, Columbus, Ohio, United States

  • The Mark H Zangmeister Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Mount Carmel Health Center West, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Doctors Hospital, Columbus, Ohio, United States

  • Miami Valley Hospital, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Premier Blood and Cancer Center, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-276-8320
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physician LLC - Englewood, Dayton, Ohio, United States

  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States

  • Grady Memorial Hospital, Delaware, Ohio, United States

  • Columbus Oncology and Hematology Associates, Dublin, Ohio, United States

  • Dublin Methodist Hospital, Dublin, Ohio, United States

  • Armes Family Cancer Center, Findlay, Ohio, United States

  • Blanchard Valley Hospital, Findlay, Ohio, United States

  • Orion Cancer Care, Findlay, Ohio, United States

  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Dayton Physicians LLC-Atrium, Franklin, Ohio, United States

  • Central Ohio Breast and Endocrine Surgery, Gahanna, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Dayton Physicians LLC-Wayne, Greenville, Ohio, United States

  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Wayne Hospital, Greenville, Ohio, United States

  • Mount Carmel Grove City Hospital, Grove City, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Zangmeister Center Grove City, Grove City, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Greater Dayton Cancer Center, Kettering, Ohio, United States

  • Kettering Medical Center, Kettering, Ohio, United States

  • Fairfield Medical Center, Lancaster, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Saint Rita's Medical Center, Lima, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • OhioHealth Mansfield Hospital, Mansfield, Ohio, United States

  • Marietta Memorial Hospital, Marietta, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • OhioHealth Marion General Hospital, Marion, Ohio, United States

  • Memorial Hospital, Marysville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, United States

  • Knox Community Hospital, Mount Vernon, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Mount Carmel New Albany Surgical Hospital, New Albany, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Licking Memorial Hospital, Newark, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Newark Radiation Oncology, Newark, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Mercy Health - Perrysburg Hospital, Perrysburg, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Southern Ohio Medical Center, Portsmouth, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Springfield Regional Cancer Center, Springfield, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Springfield Regional Medical Center, Springfield, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Mercy Health - Saint Vincent Hospital, Toledo, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Mercy Health - Saint Anne Hospital, Toledo, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Mercy Health Sylvania Radiation Oncology Center, Toledo, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States

  • Dayton Physicians LLC - Troy, Troy, Ohio, United States

  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Tarek M. Sabagh)
  • Saint Joseph Warren Hospital, Warren, Ohio, United States

  • Saint Ann's Hospital, Westerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center, Wilmington, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Saint Elizabeth Youngstown Hospital, Youngstown, Ohio, United States

  • Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Sagila George)
  • Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 405-752-3402
    Contact: Principal Investigator (Jay W. Carlson)
  • Saint Alphonsus Cancer Care Center-Baker City, Baker City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Saint Charles Health System, Bend, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · nosall@stcharleshealthcare.org · 541-706-2909
    Contact: Principal Investigator (Alison K. Conlin)
  • Clackamas Radiation Oncology Center, Clackamas, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States

  • Bay Area Hospital, Coos Bay, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · cherie.cox@bayareahospital.org · 541-269-8392
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Hood River Memorial Hospital, Hood River, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · canrsrchstudies@provdience.org · 503-215-1979
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Saint Charles Health System-Redmond, Redmond, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · 541-706-2909
    Contact: Principal Investigator (Alison K. Conlin)
  • Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Geisinger Medical Center, Danville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Ahmad Hanif)
  • Geisinger Cancer Center Dickson City, Dickson City, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · hemoncctrials@geisinger.edu · 877-204-6081
    Contact: Principal Investigator (Ahmad Hanif)
  • Pocono Medical Center, East Stroudsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-459-2901
    Contact: Principal Investigator (Ahmad Hanif)
  • Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Christopher M. Reynolds)
  • Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-374-8555
    Contact: Principal Investigator (Ahmad Hanif)
  • Lewistown Hospital, Lewistown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 717-242-7703
    Contact: Principal Investigator (Ahmad Hanif)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • Einstein Medical Center Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 215-456-3880
    Contact: Principal Investigator (Daniel Lin)
  • Geisinger Cancer Services-Pottsville, Pottsville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 800-275-6401
    Contact: Principal Investigator (Ahmad Hanif)
  • Community Medical Center, Scranton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-703-4768
    Contact: Principal Investigator (Ahmad Hanif)
  • Reading Hospital, West Reading, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 610-988-9323
    Contact: Principal Investigator (Terrence P. Cescon)
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · HemonCCTrials@geisinger.edu · 570-271-5251
    Contact: Principal Investigator (Ahmad Hanif)
  • Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Daniel Lin)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Albert C. Lockhart)
  • Avera Cancer Institute-Aberdeen, Aberdeen, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · oncregulatory@avera.org · 605-622-8700
    Contact: Principal Investigator (Heidi A. McKean)
  • Avera Cancer Institute - Mitchell, Mitchell, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-322-3096
    Contact: Principal Investigator (Heidi A. McKean)
  • Avera Cancer Institute at Pierre, Pierre, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-322-3095
    Contact: Principal Investigator (Heidi A. McKean)
  • Rapid City Regional Hospital, Rapid City, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · research@monument.health · 605-755-2370
    Contact: Principal Investigator (Abdel-Ghani Azzouqa)
  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Avera Cancer Institute, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-322-3095
    Contact: Principal Investigator (Heidi A. McKean)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Avera Cancer Institute at Yankton, Yankton, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-655-1800
    Contact: Principal Investigator (Heidi A. McKean)
  • Parkland Memorial Hospital, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-590-5582
    Contact: Principal Investigator (Timothy J. Brown)
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@utsouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Timothy J. Brown)
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Timothy J. Brown)
  • Tarrant County Hospital District/JPS Health Network, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · macosta02@jpshealth.org · 817-702-5913
    Contact: Principal Investigator (Latha S. Neerukonda)
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Timothy J. Brown)
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Suzanne.cole@utsouthwestern.edu · 972-669-7044
    Contact: Principal Investigator (Timothy J. Brown)
  • Farmington Health Center, Farmington, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Christopher D. Nevala-Plagemann)
  • University of Utah Sugarhouse Health Center, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Christopher D. Nevala-Plagemann)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Christopher D. Nevala-Plagemann)
  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · 802-225-5400
    Contact: Principal Investigator (Sarah Gillett)
  • University of Vermont Medical Center, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-4101
    Contact: Principal Investigator (Sarah Gillett)
  • University of Vermont and State Agricultural College, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-8990
    Contact: Principal Investigator (Sarah Gillett)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303
    Contact: Principal Investigator (Muneeb Rehman)
  • Inova Schar Cancer Institute, Fairfax, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-720-5210
    Contact: Principal Investigator (Arthur A. Winer)
  • Inova Fair Oaks Hospital, Fairfax, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-720-5210
    Contact: Principal Investigator (Arthur A. Winer)
  • Inova Fairfax Hospital, Falls Church, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.VanBebber@inova.org · 703-208-6650
    Contact: Principal Investigator (Arthur A. Winer)
  • Centra Alan B Pearson Regional Cancer Center, Lynchburg, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Kevin.Patel@centrahealth.com · 434-200-1495
    Contact: Principal Investigator (Bhaumik B. Patel)
  • Virginia Cancer Institute, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · smoore@vacancer.com · 804-287-3000
    Contact: Principal Investigator (Bhaumik B. Patel)
  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (Bhaumik B. Patel)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Bhaumik B. Patel)
  • VCU Community Memorial Health Center, South Hill, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · nemer.elmouallem@vcuhealth.org
    Contact: Principal Investigator (Bhaumik B. Patel)
  • Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States

    Contact: Study coordinator (Site Public Contact) · deidre.dillon@providence.org · 360-412-8958
    Contact: Principal Investigator (Alison K. Conlin)
  • Overlake Medical Center, Bellevue, Washington, United States

  • PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States

    Contact: Study coordinator (Site Public Contact) · achapman1@peacehealth.org · 360-788-8223
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Regional Cancer System-Centralia, Centralia, Washington, United States

    Contact: Study coordinator (Site Public Contact) · deidre.dillon@providence.org · 360-412-8958
    Contact: Principal Investigator (Alison K. Conlin)
  • Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Regional Cancer Partnership, Everett, Washington, United States

    Contact: Study coordinator (Site Public Contact) · marilyn.birchman@providence.org · 425-261-3529
    Contact: Principal Investigator (Alison K. Conlin)
  • Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Alison K. Conlin)
  • Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States

    Contact: Study coordinator (Site Public Contact) · research@kadlecmed.org · 509-783-4637
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Regional Cancer System-Lacey, Lacey, Washington, United States

    Contact: Study coordinator (Site Public Contact) · deidre.dillon@providence.org · 360-412-8958
    Contact: Principal Investigator (Alison K. Conlin)
  • PeaceHealth Saint John Medical Center, Longview, Washington, United States

    Contact: Study coordinator (Site Public Contact) · kmakin-bond@peacehealth.org · 360-514-2016
    Contact: Principal Investigator (Alison K. Conlin)
  • Skagit Regional Health Cancer Care Center, Mount Vernon, Washington, United States

    Contact: Study coordinator (Site Public Contact) · rcccclinicalresearch@skagitvalleyhospital.org · 360-814-2182
    Contact: Principal Investigator (Alison K. Conlin)
  • Jefferson Healthcare, Port Townsend, Washington, United States

  • Valley Medical Center, Renton, Washington, United States

    Contact: Study coordinator (Site Public Contact) · research@valleymed.org · 425-228-3440
    Contact: Principal Investigator (John A. Ellerton)
  • Swedish Medical Center-Ballard Campus, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-3086
    Contact: Principal Investigator (Alison K. Conlin)
  • Swedish Medical Center-Cherry Hill, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-3086
    Contact: Principal Investigator (Alison K. Conlin)
  • Swedish Medical Center-First Hill, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Alison K. Conlin)
  • PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States

    Contact: Study coordinator (Site Public Contact) · achapman1@peacehealth.org · 360-788-8239
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Regional Cancer System-Shelton, Shelton, Washington, United States

  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale, Washington, United States

  • Cancer Care Northwest - Spokane South, Spokane, Washington, United States

    Contact: Study coordinator (Site Public Contact) · research@ccnw.net · 509-228-1680
    Contact: Principal Investigator (Alison K. Conlin)
  • Cancer Care Northwest-Valley, Spokane, Washington, United States

    Contact: Study coordinator (Site Public Contact) · research@ccnw.net · 509-228-1680
    Contact: Principal Investigator (Alison K. Conlin)
  • Cancer Care Northwest-North Spokane, Spokane, Washington, United States

    Contact: Study coordinator (Site Public Contact) · research@ccnw.net · 509-228-1680
    Contact: Principal Investigator (Alison K. Conlin)
  • PeaceHealth Southwest Medical Center, Vancouver, Washington, United States

    Contact: Study coordinator (Site Public Contact) · kmakin-bond@peacehealth.org · 360-514-3940
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States

    Contact: Study coordinator (Site Public Contact) · Cheryl.Dodd@providence.org · 509-897-5993
    Contact: Principal Investigator (Alison K. Conlin)
  • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States

    Contact: Study coordinator (Site Public Contact) · Memorial-ClinicalTrials@yvmh.org · 509-574-3535
    Contact: Principal Investigator (John A. Ellerton)
  • Providence Regional Cancer System-Yelm, Yelm, Washington, United States

  • West Virginia University Charleston Division, Charleston, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 304-388-9944
    Contact: Principal Investigator (Ahmed A. Khalid)
  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Juli.Alford@aspirus.org · 715-623-9869
    Contact: Principal Investigator (Andrew J. Huang)
  • Duluth Clinic Ashland, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Northwest Wisconsin Cancer Center, Ashland, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Saint Luke's South Shore, Cudahy, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Aurora BayCare Medical Center, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Essentia Health-Hayward Clinic, Hayward, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Tamarack Health Hayward Medical Center, Hayward, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 218-568-4416
    Contact: Principal Investigator (Bret E. Friday)
  • Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · cancerctr@gundersenhealth.org · 608-775-2385
    Contact: Principal Investigator (Michael O. Ojelabi)
  • Marshfield Medical Center - Ladysmith, Ladysmith, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aspirus Medford Hospital, Medford, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Marshfield Medical Center - Neillsville, Neillsville, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora Cancer Care-Racine, Racine, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center, Rhinelander, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Sheboygan Physicians Group, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Essentia Health-Spooner Clinic, Spooner, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@EssentiaHealth.org · 218-786-3308
    Contact: Principal Investigator (Bret E. Friday)
  • Aspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Beth.Knetter@aspirus.org · 715-847-2353
    Contact: Principal Investigator (Andrew J. Huang)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Aurora Medical Center in Summit, Summit, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Essentia Health Saint Mary's Hospital - Superior, Superior, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 701-364-6272
    Contact: Principal Investigator (Bret E. Friday)
  • Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Aspirus Cancer Care-Wausau, Wausau, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 877-405-6866
    Contact: Principal Investigator (Andrew J. Huang)
  • Marshfield Clinic-Wausau Center, Wausau, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Aurora West Allis Medical Center, West Allis, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Edward S. James)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aspirus Cancer Care - Wisconsin Rapids, Wisconsin Rapids, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 715-422-7718
    Contact: Principal Investigator (Andrew J. Huang)
  • Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Cheyenne Regional Medical Center-West, Cheyenne, Wyoming, United States

  • Memorial Hospital of Laramie County, Cheyenne, Wyoming, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic-Cody, Cody, Wyoming, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Welch Cancer Center, Sheridan, Wyoming, United States

  • Cancer Center-Metro Medical Center Bayamon, Bayamón, Puerto Rico

  • Puerto Rico Hematology Oncology Group, Bayamón, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · 787-780-2865
    Contact: Principal Investigator (Luis J. Santos Reyes)
  • Doctors Cancer Center, Manati, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · 787-621-4397
    Contact: Principal Investigator (Luis J. Santos Reyes)
  • San Juan Community Oncology Group, San Juan, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · 787-274-3387
    Contact: Principal Investigator (Luis J. Santos Reyes)
  • Centro Comprensivo de Cancer de UPR, San Juan, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Luis J. Santos Reyes)
  • PROncology, San Juan, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · info@PRoncology.com · 787-919-7919
    Contact: Principal Investigator (Luis J. Santos Reyes)
  • San Juan City Hospital, San Juan, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · 787-763-1296
    Contact: Principal Investigator (Luis J. Santos Reyes)